190 related articles for article (PubMed ID: 30272964)
21. Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.
Silva T; Mohamed T; Shakeri A; Rao PP; Martínez-González L; Pérez DI; Martínez A; Valente MJ; Garrido J; Uriarte E; Serrão P; Soares-da-Silva P; Remião F; Borges F
J Med Chem; 2016 Aug; 59(16):7584-97. PubMed ID: 27463695
[TBL] [Abstract][Full Text] [Related]
22. Identification and optimization of nitrophenolic analogues as dopamine metabolic enzyme inhibitors for the treatment of Parkinson's disease.
Zou M; Wu Y; Lan Y; Xie H; Sun H; Liu W; Feng F; Jiang X
Bioorg Chem; 2024 Jul; 148():107488. PubMed ID: 38797066
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic evaluation of novel Catechol-O-methyltransferase inhibitors.
Pinheiro SD; Serrão MP; Silva T; Borges F; Soares-da-Silva P
Eur J Pharmacol; 2019 Mar; 847():53-60. PubMed ID: 30685433
[TBL] [Abstract][Full Text] [Related]
24. Identification of Potential Off-target Toxicity Liabilities of Catechol-O-methyltransferase Inhibitors by Differential Competition Capture Compound Mass Spectrometry.
von Kleist L; Michaelis S; Bartho K; Graebner O; Schlief M; Dreger M; Schrey AK; Sefkow M; Kroll F; Koester H; Luo Y
J Med Chem; 2016 May; 59(10):4664-75. PubMed ID: 27074629
[TBL] [Abstract][Full Text] [Related]
25. Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor.
Palma PN; Bonifácio MJ; Loureiro AI; Wright LC; Learmonth DA; Soares-da-Silva P
Drug Metab Dispos; 2003 Mar; 31(3):250-8. PubMed ID: 12584150
[TBL] [Abstract][Full Text] [Related]
26. Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.
Kiss LE; Soares-da-Silva P
J Med Chem; 2014 Nov; 57(21):8692-717. PubMed ID: 25080080
[TBL] [Abstract][Full Text] [Related]
27. Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity.
Lerner C; Masjost B; Ruf A; Gramlich V; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F
Org Biomol Chem; 2003 Jan; 1(1):42-9. PubMed ID: 12929389
[TBL] [Abstract][Full Text] [Related]
28. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
Brannan T; Prikhojan A; Yahr MD
J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
[TBL] [Abstract][Full Text] [Related]
29. Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats.
Qi Q; Cao L; Li F; Wang H; Liu H; Hao H; Hao K
Xenobiotica; 2015; 45(9):820-7. PubMed ID: 25869243
[TBL] [Abstract][Full Text] [Related]
30. Catechol metabolites of the mycotoxin zearalenone are poor substrates but potent inhibitors of catechol-O-methyltransferase.
Pfeiffer E; Wefers D; Hildebrand AA; Fleck SC; Metzler M
Mycotoxin Res; 2013 Aug; 29(3):177-83. PubMed ID: 23558779
[TBL] [Abstract][Full Text] [Related]
31. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
[TBL] [Abstract][Full Text] [Related]
32. A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods.
Tervo AJ; Nyrönen TH; Rönkkö T; Poso A
J Comput Aided Mol Des; 2003 Dec; 17(12):797-810. PubMed ID: 15124929
[TBL] [Abstract][Full Text] [Related]
33. The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-O-methyltransferase.
Cuyàs E; Verdura S; Lozano-Sánchez J; Viciano I; Llorach-Parés L; Nonell-Canals A; Bosch-Barrera J; Brunet J; Segura-Carretero A; Sanchez-Martinez M; Encinar JA; Menendez JA
Food Chem Toxicol; 2019 Jun; 128():35-45. PubMed ID: 30935952
[TBL] [Abstract][Full Text] [Related]
34. Development of an HTRF Assay for the Detection and Characterization of Inhibitors of Catechol-O-Methyltransferase.
Kimos M; Burton M; Urbain D; Caudron D; Martini M; Famelart M; Gillard M; Barrow J; Wood M
J Biomol Screen; 2016 Jun; 21(5):490-5. PubMed ID: 26582803
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase.
Lautala P; Ulmanen I; Taskinen J
Mol Pharmacol; 2001 Feb; 59(2):393-402. PubMed ID: 11160877
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
[TBL] [Abstract][Full Text] [Related]
37. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.
Detrait ER; Carr GV; Weinberger DR; Lamberty Y
Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286
[TBL] [Abstract][Full Text] [Related]
38. A single- and multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of opicapone, a novel COMT inhibitor, in rat.
Gonçalves D; Alves G; Fortuna A; Bonifácio MJ; Soares-da-Silva P; Falcão A
Neuropharmacology; 2017 Oct; 125():146-155. PubMed ID: 28734868
[TBL] [Abstract][Full Text] [Related]
39. Effect of intracerebral hydroxytyrosol and its nitroderivatives on striatal dopamine metabolism: A study by in vivo microdialysis.
Gallardo E; Madrona A; Palma-Valdés R; Espartero JL; Santiago M
Life Sci; 2015 Aug; 134():30-5. PubMed ID: 26032260
[TBL] [Abstract][Full Text] [Related]
40. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
